icu care after acute head injury
TRANSCRIPT
INTENSIVE CARE INTENSIVE CARE AFTER ACUTE HEAD AFTER ACUTE HEAD
INJURYINJURY
ModeratorModerator : : Dr Anand Dr Anand KulkarniKulkarni
PresenterPresenter: : Dr Nikhil M.PDr Nikhil M.P
IntroductionIntroduction
• One third of all trauma deathsOne third of all trauma deaths
• 15-45 years of age15-45 years of age
• 49%-road traffic accidents,28%-falls,23%-49%-road traffic accidents,28%-falls,23%-gun shot injuries and other causesgun shot injuries and other causes
• Inpatient case fatality rates Inpatient case fatality rates
all head injuries- 2.6%to6.5%all head injuries- 2.6%to6.5%
severe injuries - 15 to 50%severe injuries - 15 to 50%
• Good outcome-Glasgow outcome scale of Good outcome-Glasgow outcome scale of 1or1or22
Glasgow outcome Glasgow outcome scalescale
1= good recovery.1= good recovery.
2= moderate disability.2= moderate disability.
3= severe disability.3= severe disability.
4= vegetative state.4= vegetative state.
5= dead.5= dead.
Determinants of outcome in Determinants of outcome in acute head injuryacute head injury
Primary vs. secondary insults Primary vs. secondary insults
Little can be done about the primaryLittle can be done about the primary injury to brain injury to brain Presence and severity of secondary Presence and severity of secondary
neuronal neuronal injury injury
Physiological insults are additive in their Physiological insults are additive in their effects on outcomeeffects on outcome
Opportunity on avoiding, identifying & Opportunity on avoiding, identifying & treating-physiological derangements treating-physiological derangements
Insult Insult Mortality Mortality Significant relation Significant relation to grades within to grades within GOSGOS
Duration of Duration of hypotension hypotension (SBP< 90mm (SBP< 90mm Hg)Hg)
yesyes No No
Hypoxia (spOHypoxia (spO2 2
<90%)<90%) yesyes No No
Pyrexia>38deg Pyrexia>38deg CelsiusCelsius
yesyes No No
Intracranial Intracranial hypertension> hypertension> 30mm Hg30mm Hg
yesyes No No
Cerebral Cerebral perfusion perfusion pressure(pressure(CPP<5OmCPP<5Om
mHmHg)g)
yesyes No No
Monitoring Monitoring
A rational approach to select A rational approach to select monitoring modalities monitoring modalities
maintaining cerebral blood flow maintaining cerebral blood flow and oxygenationand oxygenation
Ischemia a consistent finding in head Ischemia a consistent finding in head injury injury
Monitoring systemic Monitoring systemic physiologyphysiology
ABP with measurement of ICPABP with measurement of ICP Placement of right atrial or Placement of right atrial or
pulmonary artery catheterpulmonary artery catheter Pulse oximetryPulse oximetry ABGABG Core temperatureCore temperature Blood sugar Blood sugar
Intracranial pressure Intracranial pressure monitoringmonitoring Normal resting ICP is 0 to 15 mm HgNormal resting ICP is 0 to 15 mm Hg Transient elevation (straining, coughing Transient elevation (straining, coughing
and and trendelenburg position) trendelenburg position)
>20 mm Hg >20 mm Hg moderate moderate >40 mm Hg >40 mm Hg severe severe
Intracranial HTN develops in 50% of Intracranial HTN develops in 50% of patients in coma patients in coma caused by severe head injury.caused by severe head injury.
50-75% after evacuation of an 50-75% after evacuation of an intracranial haematomaintracranial haematoma
postoperative haematomapostoperative haematoma
progressive swelling of focalprogressive swelling of focal
contusionscontusions
diffuse brain swellingdiffuse brain swelling
• Severe intracranial HTN can Severe intracranial HTN can result in result in
secondary injury to the brain, secondary injury to the brain, due to due to
ischemia produced by reducing ischemia produced by reducing CPP and it can also distort and CPP and it can also distort and compress the brainstem.compress the brainstem.
Measurement of Measurement of intracranial pressure in ICUintracranial pressure in ICU
• To treat intracranial HTN effectively.To treat intracranial HTN effectively.
• No reliable clinical indicators in No reliable clinical indicators in patients with head injury.patients with head injury.
• Symptoms of raised ICP are Symptoms of raised ICP are impossible to elicit in a comatose impossible to elicit in a comatose patients.patients.
• Papilledema is uncommon after head Papilledema is uncommon after head injury even in patients with injury even in patients with intracranial HTN. intracranial HTN.
INDICATIONS OF ICP INDICATIONS OF ICP MONITORINGMONITORING GCS<8 and abnormal CT scan GCS<8 and abnormal CT scan oror GCS<8 and normal CT scan but with adverse GCS<8 and normal CT scan but with adverse
featuresfeatures age>40yrsage>40yrs hypotensionhypotension decerebratedecerebrate Inability to monitor serial neurological Inability to monitor serial neurological
examinationsexaminations Treatment that increase ICP (PEEP)Treatment that increase ICP (PEEP)
ModalitiesModalities
Ventriculostomy cathetersVentriculostomy catheters
remains the preferred choice.remains the preferred choice.
allows treatment of elevated allows treatment of elevated ICP by intermittent drainage of CSF. ICP by intermittent drainage of CSF.
Microsensor transducerMicrosensor transducer
Fiberoptic transducerFiberoptic transducer
How long ?How long ?
As long as ICP remains elevatedAs long as ICP remains elevated
Active management of ICP Active management of ICP
For 3 days in the absence of For 3 days in the absence of significant significant
ICP elevationICP elevation
ComplicationsComplications
VentriculitisVentriculitis
Intracerebral hemorrhagesIntracerebral hemorrhages
contraindicationscontraindications severe coagulopathiessevere coagulopathies
Cerebral perfusion Cerebral perfusion monitoringmonitoringNormal cerebral blood flow is 54+12 Normal cerebral blood flow is 54+12
ml/100 g/min in adults and 1.06+0.03 ml/100 g/min in adults and 1.06+0.03 ml/100g/min in children.ml/100g/min in children.
Normal cerebral metabolic Normal cerebral metabolic rate(CMRO2) of oxygen is 1.5micro rate(CMRO2) of oxygen is 1.5micro mol/g/min.mol/g/min.
After head injury CMRO2 is reduced After head injury CMRO2 is reduced by approx 50% by approx 50%
Measurement of cerebral perfusion in the ICUCerebral perfusion pressureCerebral perfusion pressure simplest measuresimplest measure
MAP minus ICPMAP minus ICP
Normal lower limit of Normal lower limit of autoregulation for CPP is 50mm Hgautoregulation for CPP is 50mm Hg
Ability to auto regulate may be Ability to auto regulate may be impaired, CBF may decrease with CPP impaired, CBF may decrease with CPP values<50mm Hgvalues<50mm Hg
Assess only ischemia caused by Assess only ischemia caused by increased ICP or decreased BP increased ICP or decreased BP
•Transcranial Doppler Transcranial Doppler ultrasonography (TCD)ultrasonography (TCD)
Reduction in middle cerebral artery flow velocity-a useful marker
As ICP increases CPP decreases and highly pulsatile flow velocity pattern is seen.
Pulsatality index-describes waveform pattern
Cerebral vasospasm- TCD velocity.
•Cerebral blood flowCerebral blood flow Kety - Schmidt technique.Kety - Schmidt technique.
Inhaled Xenon techniqueInhaled Xenon technique
Both these methods are intermittent Both these methods are intermittent technique and requires the patient to be technique and requires the patient to be haemodynamically stablehaemodynamically stable
Thermal diffusion method Thermal diffusion method Laser doppler method Laser doppler method
•Jugular venous saturationJugular venous saturation
To monitor cerebral hypoxia and To monitor cerebral hypoxia and ischemiaischemia
Right jugular venous oximetry -to assess Right jugular venous oximetry -to assess the adequacy of CBF in head injurythe adequacy of CBF in head injury
Reductions in sjvo2 provide an useful Reductions in sjvo2 provide an useful marker of inadequate CBFmarker of inadequate CBF
Measured with a fiberoptic oxygen Measured with a fiberoptic oxygen saturation cathetersaturation catheter
Near infrared Near infrared spectroscopyspectroscopy
Measures cerebral oxygen Measures cerebral oxygen saturation.saturation.
Reflects changes in oxygenated, Reflects changes in oxygenated, deoxygenated and total hemoglobin.deoxygenated and total hemoglobin.
Absorbance of NIRS light by extra Absorbance of NIRS light by extra vascular blood vascular blood used to identify used to identify intracranial hematomasintracranial hematomas
Medical management of Medical management of head injuryhead injury
Surgical lesion should be ruled out Surgical lesion should be ruled out by CT scan wheneverby CT scan whenever
Unexpected severe intra cranial Unexpected severe intra cranial hypertension develops.hypertension develops.
When it is accompanied by When it is accompanied by neurological deterioration.neurological deterioration.
Refractory to medical management.Refractory to medical management.
General measuresGeneral measures
• Head elevation-Head elevation- elevating the head & elevating the head & keeping the head in neutral position keeping the head in neutral position have been standard practice for have been standard practice for management of ICP in past. management of ICP in past.
• Treatment of systemic Treatment of systemic hypertensionhypertension
common with head injury.common with head injury. SBP>DBP SBP>DBP Hyperdynamic state including Hyperdynamic state including
tachycardia & increased cardiac output.tachycardia & increased cardiac output. Autoregulation is impaired in Autoregulation is impaired in
severe head injury, systemic severe head injury, systemic hypertension may increase CBP & ICP hypertension may increase CBP & ICP and may exacerbate cerebral edemaand may exacerbate cerebral edema..
• Often resolves with sedation Often resolves with sedation
• Hydralazine & nitroprussideHydralazine & nitroprusside
• Beta & alpha blockers.Beta & alpha blockers.
Fever Fever common during recovery common during recovery
from head injury.from head injury.
potent cerebral vasodilator potent cerebral vasodilator & increase ICP and cerebral & increase ICP and cerebral metabolic requirements.metabolic requirements.
Prevention of seizures
Occurs early (<7 days) or late (>7 days) after head injury.
More common after 7 days.
Phenytoin & carbamazepine.
•Specific measuresSpecific measures
Target CPP values >60-70mmHgTarget CPP values >60-70mmHg..
Ventilatory support & use of Ventilatory support & use of hypocapnia for ICP reductionhypocapnia for ICP reduction
Patients with GCS<8Patients with GCS<8
HyperventilationHyperventilation Constricts cerebral blood vesselsConstricts cerebral blood vessels
Decreases CBV Decreases CBV
Decreases ICPDecreases ICP
• Accompanied by reduction in Accompanied by reduction in global cerebral blood flow.global cerebral blood flow.
• Hyperventilation has only short Hyperventilation has only short lived effectiveness in decreasing lived effectiveness in decreasing ICPICP
Neuromuscular blockade & Neuromuscular blockade & sedationsedation
Currently the subject is of debate.Currently the subject is of debate.Prevents rise in ICP produced by Prevents rise in ICP produced by
coughing & bucking on the tube.coughing & bucking on the tube.Increased respiratory Increased respiratory
complications.complications.Long term neuromuscular blockadeLong term neuromuscular blockade Continued paralysis.Continued paralysis. Acute myopathy.Acute myopathy.
Intravenous anesthetic agent preserve pressure auto regulation & cerebrovascular response to CO2
Barbiturates less commonly used now.
Propofol
Midazolam in combination with propofol & fentanyl.
Fluid therapy & feedingFluid therapy & feeding
Accurate fluid management may be complicated by continuing or concealed hemorrhage but every effort must be made to restore normovolemia & prevent hypertension.
By clinical & laboratory assessment of volume status and invasive hemodynamic monitoring.
30-40ml/ kg of maintenance 30-40ml/ kg of maintenance fluid per day.fluid per day.
Hypotonic & dextrose Hypotonic & dextrose containing fluids should be containing fluids should be avoided.avoided.
Increase in plasma oncotic Increase in plasma oncotic pressure in blood brain barrier pressure in blood brain barrier disruption.disruption.
Colloids effective.Colloids effective.
High nutritional requirements High nutritional requirements and feeding should be instituted and feeding should be instituted early (<24hrs)early (<24hrs)
Hyper osmolar therapyHyper osmolar therapy Mannitol traditionally used Mannitol traditionally used
to elevate plasma osmolarity & to to elevate plasma osmolarity & to decrease brain edema ( 20% decrease brain edema ( 20% solution)solution)
Reduces ICP by improving Reduces ICP by improving CPP & microcirculatory dynamics.CPP & microcirculatory dynamics.
Secondary increase in ICP Secondary increase in ICP when BBB is disrupted, fluid when BBB is disrupted, fluid overload and renal toxicity.overload and renal toxicity.
Cerebral metabolic Cerebral metabolic suppressantssuppressants
IV barbituratesIV barbiturates
cardiovascular cardiovascular depression depression
prolonged ICU stay prolonged ICU stay
pulmonary infectionpulmonary infection Excitatory amino acid antagonist Calcium channel blockers( Nimodipine) Antioxidants Corticosteroids Hypothermia
ReferencesReferences
• Text book of Neuroanaesthesia & Text book of Neuroanaesthesia & critical care, 1critical care, 1stst edition. edition.
• Anaesthesia & neurosurgery, Anaesthesia & neurosurgery, Cotrel, 2005 edition.Cotrel, 2005 edition.